|
|
High dose simvastatin in ACS: Benefits don't top risks Publish Date : 9/2/2004 12:44:00 PM Source : SkinCareIndia Health News Early initiation of simvastatin 80 mg regimen produced statistical trends toward reduction of major cardiovascular events—but also cases of myopathy. Why adults still matter to teenagers Publish Date : 9/2/2004 12:44:00 PM Source : SkinCareIndia Health News Many people think that the turbulent teenage years are a time for young people to break away from their former relationships with adults. It's a time when friends become all-consuming, leaving parents and teachers on the sidelines… GlaxoSmithKline To Begin Posting Clinical Trial Results Online Today Publish Date : 9/2/2004 12:43:00 PM Source : SkinCareIndia Health News GlaxoSmithKline on Wednesday plans to begin posting online the results of 65 clinical trials of the diabetes medication Avandia, the first part of a plan to post all company trial results online by the end of 2005 .... Pfizer Ends Senior Prescription Drug Discount Program Publish Date : 9/2/2004 12:42:00 PM Source : SkinCareIndia Health News Pfizer on Tuesday ended its prescription drug discount program targeted at seniors, called the Living Share Card, despite consumer advocates' requests for it to maintain the program until the Medicare prescription drug benefits .... Lunchbox survey 2004, facts and figures, UK Publish Date : 9/2/2004 12:41:00 PM Source : SkinCareIndia Health News Each year more than 5.5 billion lunchboxes are packed for children in the UK, according to market analysts.1 Exenatide New Drug Application Accepted for Review by the FDA Publish Date : 9/2/2004 12:40:00 PM Source : SkinCareIndia Health News Amylin Pharmaceuticals, Inc, and Eli Lilly and Company today announced that the New Drug Application (NDA) for exenatide has been accepted for review by the Food and Drug Administration (FDA). Study of Safety and Tolerability of Outpatient IV Infusions of NATRECOR® (nesiritide) Publish Date : 9/2/2004 12:38:00 PM Source : SkinCareIndia Health News Scios Inc announced the publication of results from a multi-center clinical study of the safety and tolerability of intravenous (IV) infusions of NATRECOR® (nesiritide) in advanced decompensated congestive heart failure patients .... Therapeutic Goods Administration recalls potentially unsafe eye drops, Australia Publish Date : 9/2/2004 12:37:00 PM Source : SkinCareIndia Health News Australia's medicines watchdog, the Therapeutic Goods Administration (TGA), has ordered a consumer level recall of an over the counter eye drop following spot checks by the TGA of the safety of eye drops in the market place .... Rabies in France Publish Date : 9/2/2004 12:36:00 PM Source : SkinCareIndia Health News Health authorities in France have notified WHO of a recent case of rabies in a dog with multiple opportunities to transmit the disease to humans and other animals. WHO is issuing this alert to assist French authorities .... Aldara cream encourages body's cancer fighting cells Publish Date : 9/2/2004 12:36:00 PM Source : SkinCareIndia Health News A cream that encourages the body's immune system to destroy cancer cells has been released for general use in Australia. Total Results : 3044 More Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 [73] 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 Previous Next Page |
|